Found 71 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 80 years
All genders
Phase 2
Interventional
This study investigates non-cystic fibrosis bronchiectasis. It involves participants aged 18 to 80 years to explore treatment options.The purpose of this study is to evaluate the activity and safety of an investigational medication compared to a placebo. It focuses on understanding its effects on health outcomes for the condition.Who can …
Accepts healthy volunteer
All genders
Observational
This study investigates the outcomes for mothers and their babies when the mothers receive the investigational vaccine during pregnancy. The focus is on understanding how the vaccine affects maternal health, pregnancy progress, and the newborn's health. Outcomes will be closely monitored to gather important data on these aspects.Participants in the …
18 years or above
All genders
Observational
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP), focusing on individuals with residual impairment or disability after receiving standard treatments for at least three months. The purpose of this observational study is to collect data on people with CIDP to better understand how treatments work in real-world settings.Participants will continue …
1 year or above
All genders
Observational
This study investigates eosinophilic esophagitis in patients who are being treated with an investigational medication as part of their standard care. The purpose is to gather more information about these patients and their experiences.The study focuses on understanding how the investigational medication is used in everyday care for eosinophilic esophagitis. …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the use of isatuximab combined with other novel agents in people who have relapsed or refractory myeloma.The purpose of this study is to evaluate how safe and effective the combination of isatuximab with novel agents is for treating relapsed or refractory myeloma. This study will look at …
18 years - 90 years
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication for adults with chronic pruritus of unknown origin (CPUO). The study aims to evaluate how well the investigational medication works and how safe it is for people with CPUO. The focus is on understanding its impact on the severity …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the safety and preliminary effectiveness of an investigational medication for adults with advanced solid tumors that cannot be surgically removed or have spread to other parts of the body. The study consists of two parts: a dose escalation phase to find the appropriate dose of the investigational …
2 years - 5 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on children aged 2 to less than 6 years with uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how this medication can affect these young patients who have difficulty managing their asthma symptoms.The study focuses on evaluating the …
12 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of a subcutaneous treatment for people aged 12 and older with moderate-to-severe atopic dermatitis. Participants in this study have not responded well to previous treatments, such as biologic therapies or oral JAK inhibitors.The study focuses on understanding how well the treatment works and …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates the safety, efficacy, and immune response of an investigational mRNA vaccine for adults aged 18 to 45 with moderate to severe acne. This study aims to explore new possibilities for treating this condition with a vaccine approach.The study focuses on evaluating how well the investigational mRNA vaccine …